EAHAD 2022 ABSTRACTS
The Call for Abstracts is now closed.
The EAHAD 2022 abstracts are available online here.
IMPORTANT DATES
Abstract Submission opens: 1 September 2021
Abstract Submission Deadline: 27 October 2021
Notifications to submitters: Mid-December 2021
Abstracts received after the deadline will not be accepted!
ABSTRACTS
EAHAD’s objectives are to foster scientific advancement in the field of inherited and acquired bleeding disorders in Europe, to encourage research and to provide a wide forum for discussion. Delegates who would like to present their work at the meeting, are invited to submit an abstract for consideration by the Scientific Committee.
Abstracts must describe original work, previously unpublished and not yet presented, at the time of the submission.
Scheduling of e-poster sessions and abstract presentations is at the discretion of the Scientific Committee.
The abstracts will be peer-reviewed and those selected will be presented either as oral presentations or in the e-poster session.
For standardization, the acceptable length of the abstract is of maximum 2500 characters. This includes the titles and non-visible characters, such as spaces and line breaks.
Abstract submitters will be asked their professional category during the submission process. Nurses, physiotherapists and psychosocial professionals will have the opportunity to display their e-posters during the Allied Health Professionals Day as well as during the Virtual Congress.
- 6 abstracts will be selected by the Scientific Committee to be presented orally in the SLAM session. Kindly note that the selection for these oral presentations is based on the scientific calibre of the abstract and its coherence with the other selected abstracts.
- EAHAD would like to promote young scientists in the SLAM session. Accordingly, if you wish to submit an abstract for an oral presentation, you will be asked to confirm that the presenting author will be 40 years old or under at the time of the congress.
The internet abstract submission system works best with Chrome: 16 or higher, Internet Explorer 8.0 or higher and Mozilla Firefox 5.0 or higher.
Cookies and JavaScript need to be enabled.
The objectives of the European Association for Haemophilia and Allied Disorders and its Annual Congress are to ensure the provision of the highest quality of clinical care, to educate the medical community and the general public, and to promote scientific research. Delegates who would like to present their work at the Annual EAHAD Congress, are invited to submit an abstract for consideration by the Scientific Committee.
GENERAL GUIDELINES
- Abstracts must describe original work, previously unpublished and not yet presented. In order for the abstracts to be eligible for publication, their authors must publish or present them for the first time at the EAHAD Congress. If the abstracts are accepted, published, or presented at another international or European scientific event prior to the dates of the EAHAD Congress, they are no longer eligible.
- If the abstracts are submitted to another scientific event but are not accepted, then they are eligible for publication and presentation at the EAHAD Congress.
- Scheduling of e-poster sessions and abstract presentations is at the discretion of the Scientific Committee.
- The abstracts will be peer-reviewed and those selected will be presented either as oral presentations or in the e-poster session.
- For standardisation, the acceptable length of the abstract is of maximum 2500 characters. This includes the titles and non-visible characters, such as spaces and line breaks.
- Abstract submitters will be asked their professional category during the submission process. Nurses, physiotherapists, and psychosocial professionals will have the opportunity to display their e-posters online during the Allied Health Professionals Day as well as during the Virtual Congress.
IMPORTANT DATES
Abstract Submission Opening: 1 September 2021
Abstract Submission Deadline: 27 October 2021, 23:59 CET
Notifications to submitters: mid-December 2021
Abstracts received after the deadline will not be accepted!
TECHNICAL REQUIREMENTS
- The internet abstract submission system works best with Chrome 16 or higher, Internet Explorer 8.0 or higher and Mozilla Firefox 5.0 or higher
- Cookies and JavaScript need to be enabled.
SLAM SESSION
- 6 abstracts will be selected by the Scientific Committee to be presented orally in the SLAM session. Kindly note that the selection for these oral presentations is based on the scientific calibre of the abstract and its coherence with the other selected abstracts.
- EAHAD would like to promote young scientists in the SLAM session. Accordingly, if you wish to submit an abstract for an oral presentation, you will be asked to confirm that the presenting author will be 40 years old or under at the time of the congress.
SUBMISSION GUIDELINES
- Abstracts can only be submitted online via the official abstract submission website.
- Abstracts sent by post or email will not be accepted. No exceptions will be made.
- Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline.
- Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the Congress.
- The abstracts cannot be edited after the submission deadline.
- Abstracts are accepted on a wide range of topics in haemophilia and bleeding disorders. The submitters must select the right topic for each abstract submitted. Available topics are:
- Haemophilia
- Haemophilia – Laboratory aspects, diagnostics
- Haemophilia – Preclinical
- Haemophilia – Clinical
- Von Willebrand Disease
- Von Willebrand Disease – Laboratory aspects, diagnostics
- Von Willebrand Disease – Preclinical
- Von Willebrand Disease – Clinical
- Other bleeding disorders
- Physiotherapy
- Nursing
- Psychosocial aspects
- Haemophilia
- The abstract should be structured into the following sections:
- A title which clearly indicates the nature of the investigation.
- Introduction should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
- Methods should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
- Results should contain objective data to answer the scientific question(s).
- Discussions / Conclusions should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization.
- No tables or figures are allowed in the abstract.
- Conflict of interest: It is the intent of EAHAD 2022 to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission.
- Abbreviations should be indicated in parentheses following their first mention in the text. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
- The submission of an abstract constitutes a formal commitment by the submitting author to present the abstract (if accepted) in the session and time assigned by the Programme Committee. Registration fees will not be waived.
- The presenting author of the abstract must be registered at the conference within 14 days of confirmation of abstract acceptance (the presenting author will benefit from early bird registration fee).
- Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done, and no changes can be made to the abstract after the submission deadline.
- Only original abstracts will be accepted and considered for the review.